Coya Therapeutics, Inc. (COYA) vs LENZ Therapeutics, Inc. (LENZ)

Coya Therapeutics, Inc. and LENZ Therapeutics, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and LENZ Therapeutics, Inc. are of similar size ($121.5M and $117.4M). Coya Therapeutics, Inc. has the higher net margin (−270.2% vs −586.7%) and the lower return on invested capital (−15,230.9% vs 0.00%). Across the 15 metrics below, Coya Therapeutics, Inc. leads on 8 and LENZ Therapeutics, Inc. on 7.

Valuation

Metric COYA LENZ Biotechnology median
P/E n/m n/m 7.88
P/S 14.95 5.73 11.47
P/B 2.77 0.56 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.69 0.74
EV/Sales 11.18 (4.36) 10.73
Earnings yield (20.94%) (104.34%) (28.84%)
Free cash flow yield (14.83%) (93.03%) (23.03%)

Profitability

Metric COYA LENZ Biotechnology median
Gross margin 100.00% 93.69% 65.16%
Operating margin (288.70%) (631.70%) 0.00%
Net margin (270.22%) (586.74%) 0.00%
Free cash flow margin (221.64%) (532.80%) 0.00%
Return on equity (60.54%) (59.21%) (57.72%)
Return on assets (53.66%) (55.52%) (49.22%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA LENZ Biotechnology median
Revenue growth (TTM) 108.35% — 5.64%
EPS growth (last fiscal year) (29.59%) (21.79%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA LENZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 13.55 4.73
Net debt to EBITDA 2.08 3.22 0.96

Dividend

Metric COYA LENZ Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric COYA LENZ Biotechnology median
Market cap 121.51m 117.38m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack